Asset Details
Do you wish to reserve the book?
Carbon ion radiation therapy for sinonasal malignancies: Promising results from 2282 cases from the real world
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Carbon ion radiation therapy for sinonasal malignancies: Promising results from 2282 cases from the real world
Do you wish to request the book?
Carbon ion radiation therapy for sinonasal malignancies: Promising results from 2282 cases from the real world
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Carbon ion radiation therapy for sinonasal malignancies: Promising results from 2282 cases from the real world
2020
Overview
The aim of this study is to compare the effectiveness of carbon ion radiation therapy (CIRT), proton radiation therapy (PRT), and photon‐based intensity‐modulated radiation therapy (IMRT) in the treatment of sinonasal malignancies. We identified studies through systematic review and divided them into three cohorts (CIRT group/PRT group/IMRT group). Primary outcomes of interest were overall survival (OS) and local control (LC). We pooled the outcomes with meta‐analysis and compared the survival difference among groups using Chi2 (χ2) test. A representative sample of 2282 patients with sinonasal malignancies (911 in the CIRT group, 599 in the PRT group, and 772 in the IMRT group) from 44 observation studies (7 CIRT, 16 PRT, and 21 IMRT) was included. The pooled 3‐year OS, LC, distant metastasis–free survival, and progression‐free survival rates were 67.0%, 72.8%, 69.4%, and 52.8%, respectively. Through cross‐group analysis, the OS was significantly higher after CIRT (75.1%, 95% CI: 67.1%‐83.2%) than PRT (66.2%, 95% CI: 57.7%‐74.6%; χ2 = 13.374, P < .0001) or IMRT (63.8%, 95% CI: 55.3%‐72.3%; χ2 = 23.814, P < .0001). LC was significantly higher after CIRT (80.2%, 95% CI: 73.9%‐86.5%) than PRT (72.9%, 95% CI: 63.7%‐82.0%; χ2 = 8.955, P = .003) or IMRT (67.8%, 95% CI: 59.4%‐76.2%; χ2 = 30.955, P < .0001). However, no significant difference between PRT and IMRT for OS and LC was observed. CIRT appeared to provide better OS and LC for patients with malignancies of nasal cavity and paranasal sinuses. A prospective randomized clinical trial is needed to confirm the superiority of CIRT in the treatment of sinonasal tumors.
Carbon‐ion radiation therapy achieved higher overall survival and local control rates as compared to both proton radiation therapy and photon based intensity‐modulated radiation therapy through meta‐analysis of 2, 282 patients with sinonasal malignancies from the real world. CIRT appeared to provide better OS and LC for patients with malignancies of nasal cavity and paranasal sinuses.
Publisher
John Wiley & Sons, Inc,John Wiley and Sons Inc
Subject
/ Carbon
/ carbon ion radiation therapy
/ Disease
/ Female
/ Heavy Ion Radiotherapy - adverse effects
/ Heavy Ion Radiotherapy - mortality
/ Heavy Ion Radiotherapy - statistics & numerical data
/ Humans
/ intensity‐modulated radiation therapy
/ Male
/ Nose
/ Nose Neoplasms - radiotherapy
/ Original
/ Paranasal Sinus Neoplasms - mortality
/ Paranasal Sinus Neoplasms - radiotherapy
/ Patients
/ Proton Therapy - adverse effects
/ Proton Therapy - statistics & numerical data
/ Radiotherapy, Intensity-Modulated - adverse effects
/ Radiotherapy, Intensity-Modulated - methods
/ Radiotherapy, Intensity-Modulated - mortality
/ Radiotherapy, Intensity-Modulated - statistics & numerical data
/ Sinus
/ Surgery
/ Survival
/ Tumors
